The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.


USTAALIOĞLU B., BILICI A., ERCAN S., Seker M., ORCUN A., GUMUS M.

Medical oncology (Northwood, London, England), vol.30, pp.551, 2013 (SCI-Expanded) identifier identifier identifier